Related Experiment Video
Updated: Aug 6, 2026

14:34
A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
Published on: April 3, 2026
DeorphaNN: Virtual screening of GPCR peptide agonists using AlphaFold-predicted active-state complexes and deep
Larissa Ferguson1, Sébastien Ouellet2, Elke Vandewyer3
1Neurobiology Division, MRC Laboratory of Molecular Biology, Cambridge, UK.
Molecular Cell
|July 23, 2026
Summary
Researchers developed DeorphaNN, a novel graph neural network, to identify peptide agonists for G protein-coupled receptors (GPCRs). This tool accelerates the deorphanization of orphan GPCRs by predicting effective peptide-GPCR interactions.
Area of Science:
- Biochemistry
- Computational Biology
- Pharmacology
Background:
- Peptide-activated G protein-coupled receptors (GPCRs) are crucial for physiological regulation.
- Identifying endogenous peptide agonists for GPCRs is challenging, especially for orphan GPCRs lacking characterized homologs.
- Existing methods offer limited predictive power for novel peptide-GPCR pairings.
Purpose of the Study:
- To develop a computational method for predicting peptide agonists of GPCRs.
- To leverage structural predictions and deep learning for prioritizing experimental screening.
- To accelerate the deorphanization of orphan GPCRs.
Main Methods:
- Utilized a dataset of experimentally validated peptide-GPCR interactions from *Caenorhabditis elegans*.
- Employed AlphaFold-multimer (AF-multimer) confidence metrics and active-state templates for discriminating interactions.
- Developed DeorphaNN, a graph neural network integrating structural predictions, interatomic interactions, and deep learning embeddings.
Main Results:
- AF-multimer confidence metrics showed partial discrimination of agonist complexes, improved by active-state templates.
- Feature analysis indicated that pair representations in AF-multimer provided superior signals compared to single representations.
- DeorphaNN successfully generalized across species, demonstrating strong performance on annelid and human benchmarks.
- Experimental validation confirmed predicted agonists for two orphan GPCRs.
Conclusions:
- DeorphaNN effectively prioritizes putative peptide agonists for GPCRs.
- The developed method accelerates the challenging process of peptide-GPCR deorphanization.
- This approach holds significant potential for discovering novel peptide-GPCR interactions across diverse species.